The overall goal of our research program is to identify and understand the mechanisms of action of specificgenes that modulate risk for cancer development in inbred mice. These studies will provide insights into thesignaling pathways critical for hepatocarcinogenesis in mice, as well as models for understanding the actionof modifier genes for cancer risk in humans. We have identified the Hcs7 locus as the major determinant ofthe high susceptibility of C3H/HeJ (C3H) and CBA/J mice to liver tumor induction relative to C57BL/6J (B6)mice and demonstrated that this gene is located on distal Chromosome 1. We also found that one of thesusceptibility genes, Hcf2, carried by sensitive C57BR/cdJ (BR) mice mapped to the same region.Comparative studies of hepatocarcinogenesis in C3H, BR, and B6 mice by our group and othersdemonstrate that the Hcs7 and Hcf2 loci act cell autonomously to control the growth or development ofpreneoplastic hepatic lesions, but the molecular identities of these genes are still unknown. We havelocalized the Hcs7gene to a 6.4 Mbp interval on Chromosome 1. We propose to elucidate the mechanismsby which Hcs7 modulates liver cancer risk through the following approaches. First, we will determine themolecular identity of Hcs7 through positional cloning. We will prioritize candidate genes based on mappingto sub-centiMorgan resolution, analysis of shared SIMP haplotypes for relevant strains, hepatic geneexpression, and functional criteria. Candidates will then be tested by transgenesis using Bacterial ArtificialChromosome (BAG) clones or gene replacement. Second, we will elucidate the biological basis for Hcs7modulation of cancer risk by comparing Hcs7 BAG transgenic or allelic replacement strains to controlparental or congenic mice for phenotypes related to hepatocarcinogenesis. Finally, we will determine themolecular mechanisms by which Hcs7 acts through analysis of hepatic gene expression in BAG transgenicand congenic mice, and characterization of mice carrying germ-line or liver-specific null mutations in Hcs7.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA022484-26A2
Application #
7120264
Study Section
Subcommittee G - Education (NCI)
Project Start
2006-04-01
Project End
2010-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
26
Fiscal Year
2006
Total Cost
$177,500
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Xia, Chuanwu; Rwere, Freeborn; Im, Sangchoul et al. (2018) Structural and Kinetic Studies of Asp632 Mutants and Fully Reduced NADPH-Cytochrome P450 Oxidoreductase Define the Role of Asp632 Loop Dynamics in the Control of NADPH Binding and Hydride Transfer. Biochemistry 57:945-962
Oberley, Christopher C; Bilger, Andrea; Drinkwater, Norman R (2015) Genetic background determines if Stat5b suppresses or enhances murine hepatocarcinogenesis. Mol Carcinog 54:959-70
Kennedy, Gregory D; Nukaya, Manabu; Moran, Susan M et al. (2014) Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors. Toxicol Sci 140:135-43
Copp, Richard R; Peebles, Daniel D; Soref, Cheryl M et al. (2013) Radioprotective efficacy and toxicity of a new family of aminothiol analogs. Int J Radiat Biol 89:485-92
Figueiredo, Marxa L; Stein, Timothy J; Jochem, Adam et al. (2012) Mutant Hras(G12V) and Kras(G12D) have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice. Liver Int 32:582-91
Stein, Timothy J; Jochem, Adam; Holmes, Katie E et al. (2011) Effect of mutant ?-catenin on liver growth homeostasis and hepatocarcinogenesis in transgenic mice. Liver Int 31:303-12
Copp, Richard R; Peebles, Daniel D; Fahl, William E (2011) Synthesis and growth regulatory activity of a prototype member of a new family of aminothiol radioprotectors. Bioorg Med Chem Lett 21:7426-30
Stein, Timothy J; Bowden, Margaret; Sandgren, Eric P (2011) Minimal cooperation between mutant Hras and c-myc or TGF? in the regulation of mouse hepatocyte growth or transformation in vivo. Liver Int 31:1298-305
Xia, Chuanwu; Hamdane, Djemel; Shen, Anna L et al. (2011) Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding. J Biol Chem 286:16246-60
Figueiredo, Marxa L; Wentworth, Kristin M; Sandgren, Eric P (2010) Quantifying growth and transformation frequency of oncogene-expressing mouse hepatocytes in vivo. Hepatology 52:634-43

Showing the most recent 10 out of 258 publications